| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 141,496 | 206,983 | 232,604 | 258,598 | | Cost of Revenue | 144,526 | 177,237 | 202,541 | 230,597 | | | Gross Profit | (3,030) | 29,746 | 30,063 | 28,001 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,736 | 16,826 | 15,986 | 7,210 | | Non Recurring |
-
|
-
|
-
| 9,242 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (15,766) | 12,920 | 14,077 | 11,549 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 644 | 647 | 1,409 | (37,748) | | Earnings Before Interest And Taxes | (15,122) | 13,567 | 15,486 | (26,199) | | Interest Expense | 3,997 | 3,878 | 3,944 | 3,696 | | Income Before Tax | (19,119) | 9,689 | 11,542 | (29,895) | | Income Tax Expense | (8,006) | 3,779 | 4,501 | (11,489) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,113) | 5,910 | 7,041 | (18,406) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,113) | 5,910 | 7,041 | (18,406) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,113) | $5,910 | $7,041 | ($18,406) |
|
0.03% Nasdaq 
0.01 (0.12%) 
Income Statement
